Comprehensive analysis of common serum liver enzymes as prospective predictors of hepatocellular carcinoma in HBV patients.

Serum liver enzymes are frequently tested in clinics to aid disease diagnosis. Large observational studies indicated that these enzymes might predict cancer risk and mortality. However, no prospective study has reported on their relationships with the risk of HBV-related hepatocellular carcinoma (HC...

Full description

Bibliographic Details
Main Authors: Hie-Won Hann, Shaogui Wan, Ronald E Myers, Richard S Hann, Jinliang Xing, Bicui Chen, Hushan Yang
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3480412?pdf=render
id doaj-2e6f02471fdf43e097004dcda45e179a
record_format Article
spelling doaj-2e6f02471fdf43e097004dcda45e179a2020-11-24T20:50:41ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-01710e4768710.1371/journal.pone.0047687Comprehensive analysis of common serum liver enzymes as prospective predictors of hepatocellular carcinoma in HBV patients.Hie-Won HannShaogui WanRonald E MyersRichard S HannJinliang XingBicui ChenHushan YangSerum liver enzymes are frequently tested in clinics to aid disease diagnosis. Large observational studies indicated that these enzymes might predict cancer risk and mortality. However, no prospective study has reported on their relationships with the risk of HBV-related hepatocellular carcinoma (HCC).We evaluated the predictive values of four routinely tested liver enzymes (alanine aminotransferase [ALT], aspartate aminotransferase [AST], alkaline phosphatase [ALP], and gamma-glutamyltransferase [GGT]) in HCC risk in a prospectively enrolled clinical cohort of 588 Korean American HBV patients. For all four enzymes, the baseline level as well as the average and maximum levels during the first 1 or 2 years of follow-up were analyzed using multivariate Cox proportional hazards model. Patients were categorized into a normal or an elevated group based on the clinical cut-off of each enzyme. During a median follow-up of 7.5 years, 52 patients (incidence rate, 8.8%) developed HCC. The incidence rates were higher in the elevated groups for all four enzymes. The most significant finding was for GGT, with the highest incidence rate of 16.4% in the elevated group compared to 4.6% in the normal group (P<0.001). Compared to patients with normal baseline GGT, those with elevated GGT exhibited a significantly increased HCC risk with a hazards ratio (HR) of 2.60 (95% confidence interval [CI], 1.41-4.77, P = 0.002). Further analyses revealed a cumulative effect between baseline GGT and ALP (HR = 3.41, 95% CI 1.54-7.56, P = 0.003).Serum GGT might predict HCC risk in HBV patients individually or jointly with other enzymes.http://europepmc.org/articles/PMC3480412?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Hie-Won Hann
Shaogui Wan
Ronald E Myers
Richard S Hann
Jinliang Xing
Bicui Chen
Hushan Yang
spellingShingle Hie-Won Hann
Shaogui Wan
Ronald E Myers
Richard S Hann
Jinliang Xing
Bicui Chen
Hushan Yang
Comprehensive analysis of common serum liver enzymes as prospective predictors of hepatocellular carcinoma in HBV patients.
PLoS ONE
author_facet Hie-Won Hann
Shaogui Wan
Ronald E Myers
Richard S Hann
Jinliang Xing
Bicui Chen
Hushan Yang
author_sort Hie-Won Hann
title Comprehensive analysis of common serum liver enzymes as prospective predictors of hepatocellular carcinoma in HBV patients.
title_short Comprehensive analysis of common serum liver enzymes as prospective predictors of hepatocellular carcinoma in HBV patients.
title_full Comprehensive analysis of common serum liver enzymes as prospective predictors of hepatocellular carcinoma in HBV patients.
title_fullStr Comprehensive analysis of common serum liver enzymes as prospective predictors of hepatocellular carcinoma in HBV patients.
title_full_unstemmed Comprehensive analysis of common serum liver enzymes as prospective predictors of hepatocellular carcinoma in HBV patients.
title_sort comprehensive analysis of common serum liver enzymes as prospective predictors of hepatocellular carcinoma in hbv patients.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2012-01-01
description Serum liver enzymes are frequently tested in clinics to aid disease diagnosis. Large observational studies indicated that these enzymes might predict cancer risk and mortality. However, no prospective study has reported on their relationships with the risk of HBV-related hepatocellular carcinoma (HCC).We evaluated the predictive values of four routinely tested liver enzymes (alanine aminotransferase [ALT], aspartate aminotransferase [AST], alkaline phosphatase [ALP], and gamma-glutamyltransferase [GGT]) in HCC risk in a prospectively enrolled clinical cohort of 588 Korean American HBV patients. For all four enzymes, the baseline level as well as the average and maximum levels during the first 1 or 2 years of follow-up were analyzed using multivariate Cox proportional hazards model. Patients were categorized into a normal or an elevated group based on the clinical cut-off of each enzyme. During a median follow-up of 7.5 years, 52 patients (incidence rate, 8.8%) developed HCC. The incidence rates were higher in the elevated groups for all four enzymes. The most significant finding was for GGT, with the highest incidence rate of 16.4% in the elevated group compared to 4.6% in the normal group (P<0.001). Compared to patients with normal baseline GGT, those with elevated GGT exhibited a significantly increased HCC risk with a hazards ratio (HR) of 2.60 (95% confidence interval [CI], 1.41-4.77, P = 0.002). Further analyses revealed a cumulative effect between baseline GGT and ALP (HR = 3.41, 95% CI 1.54-7.56, P = 0.003).Serum GGT might predict HCC risk in HBV patients individually or jointly with other enzymes.
url http://europepmc.org/articles/PMC3480412?pdf=render
work_keys_str_mv AT hiewonhann comprehensiveanalysisofcommonserumliverenzymesasprospectivepredictorsofhepatocellularcarcinomainhbvpatients
AT shaoguiwan comprehensiveanalysisofcommonserumliverenzymesasprospectivepredictorsofhepatocellularcarcinomainhbvpatients
AT ronaldemyers comprehensiveanalysisofcommonserumliverenzymesasprospectivepredictorsofhepatocellularcarcinomainhbvpatients
AT richardshann comprehensiveanalysisofcommonserumliverenzymesasprospectivepredictorsofhepatocellularcarcinomainhbvpatients
AT jinliangxing comprehensiveanalysisofcommonserumliverenzymesasprospectivepredictorsofhepatocellularcarcinomainhbvpatients
AT bicuichen comprehensiveanalysisofcommonserumliverenzymesasprospectivepredictorsofhepatocellularcarcinomainhbvpatients
AT hushanyang comprehensiveanalysisofcommonserumliverenzymesasprospectivepredictorsofhepatocellularcarcinomainhbvpatients
_version_ 1716803803859124224